imiquimod has been researched along with Graft vs Host Disease in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bennett, CL; Chakraverty, R; Chorro, L; Conlan, T; Fallah-Arani, F; Flutter, B; Geissmann, F; Goold, H; Means, TK; Trouillet, C | 1 |
Bezak, KB; Durakovic, N; Fuchs, EJ; Luznik, L; Murphy, GF; Radojcic, V; Skarica, M | 1 |
2 other study(ies) available for imiquimod and Graft vs Host Disease
Article | Year |
---|---|
Langerhans cells regulate cutaneous injury by licensing CD8 effector cells recruited to the skin.
Topics: Aminoquinolines; Animals; Cell Communication; Cells, Cultured; Chimera; Cytotoxicity, Immunologic; Epidermis; Gene Expression Regulation; Graft vs Host Disease; Granzymes; Imiquimod; Interferon-gamma; Langerhans Cells; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Transgenic; RNA, Messenger; T-Lymphocytes, Cytotoxic; TNF-Related Apoptosis-Inducing Ligand; Toll-Like Receptors; Tumor Necrosis Factor-alpha | 2011 |
Host-derived Langerhans cells persist after MHC-matched allografting independent of donor T cells and critically influence the alloresponses mediated by donor lymphocyte infusions.
Topics: Adjuvants, Immunologic; Aminoquinolines; Animals; Bone Marrow Transplantation; Flow Cytometry; Graft vs Host Disease; Graft vs Host Reaction; Imiquimod; Langerhans Cells; Lymph Nodes; Major Histocompatibility Complex; Mice; Skin; T-Lymphocytes; Transplantation Chimera; Transplantation, Homologous; Transplants | 2006 |